# Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)

> **NCT00653913** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 18 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** SCH 58235
- **DRUG:** pitavastatin

## Key facts

- **NCT ID:** NCT00653913
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653913, "Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00653913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*